Novel technique for DSAEK yields thin grafts

Article

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

The team, led by Professor Joaquim Neto Murta (Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal), prepared 25 DSAEK grafts using a novel technique. The technique involved two sequential cuts, the first of which was of variable thickness using a femtosecond laser and the second was performed using a 300 µm microkeratome head.

To analyse the new technique the team measured spectacle corrected visual acuity and endothelial cell density (with specular microscopy and anterior segment optical coherence tomography) at the periphery and the centre of the grafts both preoperatively and at 1, 3 and 6 months postoperatively.

No irregular cuts or perforations occurred during tissue preparation and the team found that central graft thickness was 79.6 µm and 69.3 µm at 3 and 6 months respectively. Spectacle corrected distance visual acuity was found to improve from 0.91 logMAR preoperatively to 0.11 logMAR at 6 months post-op.

In conclusion, the novel technique was deemed to provide consistently thin grafts of lower than 100 µm and good visual acuity outcomes. Additionally, no graft detachments were encountered and so there was no wastage of donor tissue.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.